Radionuclide therapy a promising option to treat HER2 breast cancer
The radionuclide treatment combines radioactive iodine therapy with single-domain antibodies…
The radionuclide treatment combines radioactive iodine therapy with single-domain antibodies to target the HER2 antigen.